Invex Therapeutics Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Invex Therapeutics Ltd. on 6ix
In the deck
Story so far
Earlier from Invex Therapeutics
- Invex Provides Development Update
- Quarterly Report and Appendix 4C with appendix
- Quarterly Report and Appendix 4C
- Initial FDA and EMA Advice on Presendin Development
- Notice of Allowance for Key US Exenatide Patent
Later from Invex Therapeutics
- Chairmans Address to Shareholders and Presentation
- Invex Successfully Concludes Protocol Assistance with EMA
- Appendix 4C - quarterly
- Invex Granted Type C Meeting with FDA
- Invex Receives Written Response from FDA on Type C Meeting
Follow Invex Therapeutics into a list and get an email when it puts out news.
Follow Invex Therapeutics